Ubs Group Ag Sight Sciences, Inc. Call Options Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SGHT
# of Institutions
69Shares Held
21.1MCall Options Held
33.2KPut Options Held
27.7K-
Kck Ltd. Tortola, D84.65MShares$31 Million22.26% of portfolio
-
Bank Of America Corp Charlotte, NC3.16MShares$21.1 Million0.0% of portfolio
-
Jackson Square Partners, LLC San Francisco, CA1.61MShares$10.7 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.43MShares$9.56 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $319M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...